Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|March 6, 2018
Development of a M cell-targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17Juha-Pekka Mattila, Leonardo Mirandola, Maurizio Chiriva-InternatiJournal of Translational Medicine|December 28, 2019
A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockadeLeonardo Mirandola, Maurizio Chiriva-Internati, Robert Bresalier, et al.Cancer Letters|June 10, 2011
Notch-ing from T-cell to B-cell lymphoid malignanciesLeonardo Mirandola, Paola Comi, Everardo Cobos, et al.Immunity & Ageing : I & A|April 19, 2012
Aging, cancer, and cancer vaccinesPaolo Mazzola, Saba Radhi, Leonardo Mirandola, et al.International Reviews of Immunology|May 12, 2011
Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapiesMaurizio Chiriva-Internati, Leonardo Mirandola, W Martin Kast, et al.Frontiers in Immunology|August 30, 2018
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine MilieuMichela Colombo, Leonardo Mirandola, Maurizio Chiriva-Internati, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|November 11, 2008
Down-regulation of Notch1 expression is involved in HL-60 cell growth inhibition induced by 4-hydroxynonenal, a product of lipid peroxidationStefania Pizzimenti, Giuseppina Barrera, Elisabetta Calzavara, et al.Plos One|July 19, 2011
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myelomaLeonardo Mirandola, Yuefei Yu, Kitty Chui, et al.BMC Cancer|September 20, 2011
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4Leonardo Mirandola, Yuefei Yu, Marjorie R Jenkins, et al.Plos One|April 17, 2014
Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic miceHongqing Zhu, Maohua Cao, Leonardo Mirandola, et al.Pageof 4